162 related articles for article (PubMed ID: 38791546)
1. LPA
Solís KH; Romero-Ávila MT; Rincón-Heredia R; García-Sáinz JA
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791546
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic Acid Receptor 3 (LPA3): Signaling and Phosphorylation Sites.
Solís KH; Romero-Ávila MT; Rincón-Heredia R; García-Sáinz JA
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928196
[TBL] [Abstract][Full Text] [Related]
3. Roles of the α
Hernández-Espinosa DA; Alcántara-Hernández R; Solís KH; García-Sáinz JA
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069285
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.
Timossi C; Ortiz-Elizondo C; Pineda DB; Dias JA; Conn PM; Ulloa-Aguirre A
Mol Cell Endocrinol; 2004 Aug; 223(1-2):17-26. PubMed ID: 15279907
[TBL] [Abstract][Full Text] [Related]
5. A549 cells as a model to study endogenous LPA
Carmona-Rosas G; Alfonzo-Méndez MA; Hernández-Espinosa DA; Romero-Ávila MT; García-Sáinz JA
Eur J Pharmacol; 2017 Nov; 815():258-265. PubMed ID: 28943105
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
7. LPA
Wang F; Liu S; Pei J; Cai L; Liu N; Liang T; Dong X; Cong X; Chun J; Chen J; Hu S; Chen X
Theranostics; 2020; 10(24):10892-10907. PubMed ID: 33042260
[No Abstract] [Full Text] [Related]
8. Differential targeting of lysophosphatidic acid LPA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
[TBL] [Abstract][Full Text] [Related]
9. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A
Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid (LPA) as a modulator of plasma membrane Ca
Sant'Anna JF; Baldez VS; Razuck-Garrão NA; Lemos T; Diaz BL; Einicker-Lamas M
J Physiol Biochem; 2021 May; 77(2):321-329. PubMed ID: 33704695
[TBL] [Abstract][Full Text] [Related]
12. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
13. Role of the intracellular domains of the human FSH receptor in G(alphaS) protein coupling and receptor expression.
Ulloa-Aguirre A; Uribe A; Zariñán T; Bustos-Jaimes I; Pérez-Solis MA; Dias JA
Mol Cell Endocrinol; 2007 Jan; 260-262():153-62. PubMed ID: 17045734
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.
Alcántara-Hernández R; Hernández-Méndez A; Campos-Martínez GA; Meizoso-Huesca A; García-Sáinz JA
PLoS One; 2015; 10(10):e0140583. PubMed ID: 26473723
[TBL] [Abstract][Full Text] [Related]
15. Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity.
Hwang SH; Shin TJ; Choi SH; Cho HJ; Lee BH; Pyo MK; Lee JH; Kang J; Kim HJ; Park CW; Shin HC; Nah SY
Mol Cells; 2012 Feb; 33(2):151-62. PubMed ID: 22286231
[TBL] [Abstract][Full Text] [Related]
16. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Li HY; Oh YS; Choi JW; Jung JY; Jun HS
Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
[TBL] [Abstract][Full Text] [Related]
17. RAFTK/Pyk2 mediates LPA-induced PC12 cell migration.
Park SY; Schinkmann KA; Avraham S
Cell Signal; 2006 Jul; 18(7):1063-71. PubMed ID: 16199135
[TBL] [Abstract][Full Text] [Related]
18. The Src homology 3 binding domain is required for lysophosphatidic acid 3 receptor-mediated cellular viability in melanoma cells.
Jia W; Tran SK; Ruddick CA; Murph MM
Cancer Lett; 2015 Jan; 356(2 Pt B):589-96. PubMed ID: 25304369
[TBL] [Abstract][Full Text] [Related]
19. The short third intracellular loop and cytoplasmic tail of bitter taste receptors provide functionally relevant GRK phosphorylation sites in TAS2R14.
Kim D; Castaño M; Lujan LK; Woo JA; Liggett SB
J Biol Chem; 2021; 296():100216. PubMed ID: 33465377
[TBL] [Abstract][Full Text] [Related]
20. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
